El Farmaceutica India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.63 M
as on 24-10-2024
- Revenue 17.39%
(FY 2023)
- Profit -157.53%
(FY 2023)
- Ebitda 31.12%
(FY 2023)
- Net Worth -18.32%
(FY 2023)
- Total Assets 163.47%
(FY 2023)
About El Farmaceutica India
The Corporate was formerly known as Essatto Life Sciences India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.63 M.
Vatika Grover, Dilip Kumar, Om Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U74110DL2016PTC307369
- Company No.
307369
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does El Farmaceutica India Private Limited offer?
El Farmaceutica India Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Multivitamin Supplements, Vitamins & Supplements, Multivitamins.
Who are the key members and board of directors at El Farmaceutica India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vatika Grover  | Additional Director | 01-Nov-2018 | Current |
| Dilip Kumar | Director | 20-Oct-2016 | Current |
| Om Singh | Additional Director | 08-Apr-2024 | Current |
| Saurabh Kumar | Additional Director | 08-Apr-2024 | Current |
Financial Performance of El Farmaceutica India.
El Farmaceutica India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.39% increase. The company also saw a substantial fall in profitability, with a 157.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of El Farmaceutica India?
In 2023, El Farmaceutica India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ashtaka Ingredients Private LimitedActive 1 month 9 daysVatika Grover, Dilip Kumar and 2 more are mutual person
- Devsevit Ayurveda Private LimitedActive 11 years 7 months
Vatika Grover, Dilip Kumar and 2 more are mutual person
- Bodhi's Hill Eco Resorts Private LimitedActive 3 years 11 months
Vatika Grover and Dilip Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 May 2023 | ₹4.63 M | Open |
How Many Employees Work at El Farmaceutica India?
El Farmaceutica India has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of El Farmaceutica India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped El Farmaceutica India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
